Metabolic laparoscopic gastric bypass for obese patients with type 2 diabetes

Obesity Surgery

Volumn 21, Issue 11, 2011, Pages 1643-1649

  Nora, Mário ^a   Guimarães, Marta ^a   Almeida, Rui ^a   Martins, Paulo ^a   Gonçalves, Gil ^a   Freire, Maria José ^a   Ferreira, Tiago ^a   Freitas, Cláudia ^a   Monteiro, Mariana P ^a,b  

^a Centro Hospitalar de Entre O Douro e Vouga   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Bariatric surgery; Gastric bypass; Obesity; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LIPID;

ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DIABETIC OBESITY; DIABETIC PATIENT; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HORMONE METABOLISM; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; ROUX Y ANASTOMOSIS; WEIGHT REDUCTION;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES;

EID: 84155167446     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0418-x     Document Type: Article

References (41)

1. T Kelly W Yang CS Chen, et al. 2008 Global burden of obesity in 2005 and projections to 2030 Int J Obes 32 9 1431 1437 10.1038/ijo.2008.102 1:STN:280:DC%2BD1cngsVamtQ%3D%3D
2. I Do Carmo O Dos Santos J Camolas, et al. 2008 Overweight and obesity in Portugal: national prevalence in 2003-2005 Obes Rev 9 11 19 18034792 1:STN:280:DC%2BD2sjmtFKnsg%3D%3D
3. DM Muoio CB Newgard 2008 Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes Rev Mol Cell Biol 9 3 193 205 10.1038/nrm2327 1:CAS:528:DC%2BD1cXitlGnurg%3D
4. MI Harris 1998 Diabetes in America: epidemiology and scope of the problem Diabetes Care 21 Suppl 3 C11 C14 9850480
5. National Task Force on the Prevention and Treatment of Obesity 2000 Overweight, obesity, and health risk Arch Intern Med 160 898 904 10.1001/archinte.160.7.898
6. DJ Goldstein 1992 Beneficial health effects of modest weight loss Int J Obes Relat Metab Disord 16 6 397 415 1322866 1:STN:280:DyaK38zlsFWruw%3D%3D
7. HW Rodbard PS Jellinger JA Davidson, et al. 2009 Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control Endocr Pract 15 6 540 559 19858063
8. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin or metformin in patients with newly diagnosed non-insulin-dependent diabetes mellitus followed for three years. BMJ 1995; 310:83-8.
9. P King I Peacock R Donnelly 1999 The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes Br J Clin Pharmacol 48 5 643 648 10594464 10.1046/j.1365-2125.1999.00092.x 1:STN:280:DC%2BD3c%2FmtlKltg%3D%3D
10. JB Dixon 2009 Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes World J Surg 33 10 2014 2021 19421812 10.1007/s00268-009-0062-y
11. KJ Frachetti AB Goldfine 2009 Bariatric surgery for diabetes management Curr Opin Endocrinol Diab Obes 16 2 119 124 10.1097/MED.0b013e32832912e7
12. TD Adams RE Gress SC Smith, et al. 2007 Long-term mortality after gastric bypass surgery N Engl J Med 357 8 753 761 17715409 10.1056/NEJMoa066603 1:CAS:528:DC%2BD2sXpsF2iu7k%3D
13. M Parikh P Ayoung-Chee E Romanos, et al. 2007 Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion J Am Coll Surg 205 5 631 635 17964437 10.1016/j.jamcollsurg.2007.05.033
14. L Sjöström AK Lindroos M Peltonen, et al. 2004 Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery N Engl J Med 351 26 2683 2693 15616203 10.1056/NEJMoa035622
15. H Buchwald Y Avidor E Braunwald, et al. 2004 Bariatric surgery: a systematic review and meta-analysis JAMA 292 14 1724 1737 15479938 10.1001/jama.292.14.1724 1:CAS:528:DC%2BD2cXos1OjtLg%3D
16. WJ Pories MS Swanson KG MacDonald, et al. 1995 Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus Ann Surg 222 339 350 7677463 10.1097/00000658-199509000-00011 1:STN:280:DyaK2Mvgsl2ltA%3D%3D
17. American Diabetes Association 2010 Standards of medical care in diabetes Diabetes Care 33 Suppl 1 S11 S61 10.2337/dc10-S011
18. F Rubino LM Kaplan PR Schauer 2010 Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus Ann Surg 251 3 399 405 19934752 10.1097/SLA.0b013e3181be34e7
19. F Rubino A Forgione DE Cummings, et al. 2006 The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes Ann Surg 244 5 741 749 17060767 10.1097/01.sla.0000224726.61448.1b
20. R Cohen JS Pinheiro JL Correa, et al. 2006 Laparoscopic Roux-en-Y gastric bypass for BMI<35 kg/m(2): a tailored approach Surg Obes Relat Dis 2 3 401 404 16925363 10.1016/j.soard.2006.02.011
21. AL DePaula AL Macedo N Rassi, et al. 2008 Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35 Surg Endosc 22 3 706 716 17704886 10.1007/s00464-007-9472-9 1:STN:280: DC%2BD1c7lsFeqsg%3D%3D
22. Zervos EE, Agle SC, Warren AJ, et al. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg. 2010; 210(5):564-72, 572-4.
23. BT Bikman D Zheng WJ Pories, et al. 2008 Mechanism for improved insulin sensitivity after gastric bypass surgery J Clin Endocrinol Metab 93 12 4656 4663 18765510 10.1210/jc.2008-1030 1:CAS:528:DC%2BD1cXhsVyqtb3K
24. AC Wittgrove GW Clark 2000 Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3-60 month follow-up Obes Surg 10 233 239 10929154 10.1381/096089200321643511 1:STN:280:DC%2BD3cvotFOlsQ%3D%3D
25. F Rubino PR Schauer LM Kaplan, et al. 2010 Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action Annu Rev Med 61 393 411 20059345 10.1146/annurev.med.051308.105148 1:CAS:528:DC%2BC3cXisFylsbc%3D
26. BG Leifsson HG Gislason 2005 Laparoscopic Roux-en-Y gastric bypass with 2-metre long biliopancreatic limb for morbid obesity: technique and experience with the first 150 patients Obes Surg 15 1 35 42 15760497 10.1381/ 0960892052993396
27. R Fetner J McGinty C Russell, et al. 2005 Incretins, diabetes, and bariatric surgery: a review Surg Obes Relat Dis 1 6 589 597 16925299 10.1016/j.soard.2005.09.001
28. H Buchwald R Estok K Fahrbach, et al. 2009 Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am J Med 122 3 248 256 19272486 10.1016/j.amjmed.2008.09.041
29. PR Schauer B Burguera S Ikramuddin, et al. 2003 Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus Ann Surg 238 4 467 484 14530719
30. HJ Sugerman LG Wolfe DA Sica, et al. 2003 Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss Ann Surg 237 6 751 756 12796570
31. WJ Pories JF Caro EG Flickinger, et al. 1987 The control of diabetes mellitus (NIDDM) in the morbidly obese with the Greenville gastric bypass Ann Surg 206 3 316 323 3632094 10.1097/00000658-198709000-00009 1:STN:280: DyaL2szisFWltA%3D%3D
32. JS Pinheiro CA Schiavon PB Pereira, et al. 2008 Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients Surg Obes Relat Dis 4 4 521 525 18539540 10.1016/j.soard.2007.12.016
33. G Mingrone L Castagneto-Gissey 2009 Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery Diab Metab 35 518 523 10.1016/S1262-3636(09)73459-7 1:STN:280:DC%2BC3c7jslWqsA%3D%3D
34. MS Hickey WJ Pories KG MacDonald Jr, et al. 1998 A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 227 5 637 643 9605655 10.1097/00000658-199805000-00004 1:STN:280:DyaK1c3ms1KqsA%3D%3D
35. WJ Pories 2004 Diabetes: the evolution of a new paradigm Ann Surg 239 1 12 13 14685094 10.1097/01.sla.0000102990.47956.98
36. DL Sarson N Scopinaro SR Bloom 1981 Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity Int J Obes 5 5 471 480 6796532 1:STN:280:DyaL38%2FnsFSitQ%3D%3D
37. R Morínigo V Moizé M Musri, et al. 2006 Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects J Clin Endocrinol Metab 91 5 1735 1740 16478824 10.1210/jc.2005-0904
38. B Laferrère S Heshka K Wang, et al. 2007 Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 7 1709 1716 17416796 10.2337/dc06-1549
39. YD Podnos JC Jimenez SE Wilson, et al. 2003 Complications after laparoscopic gastric bypass: a review of 3464 cases Arch Surg 138 9 957 961 12963651 10.1001/archsurg.138.9.957
40. PR Schauer S Ikramuddin W Gourash, et al. 2000 Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity Ann Surg 232 4 515 529 10998650 10.1097/00000658-200010000-00007 1:STN:280:DC%2BD3M%2Fhs1eitA%3D%3D
41. SA Shikora JJ Kim ME Tarnoff, et al. 2005 Laparoscopic Roux-en-Y gastric bypass: results and learning curve of a high-volume academic program Arch Surg 140 4 362 367 15837887 10.1001/archsurg.140.4.362